Status:
COMPLETED
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Informed consent.
- Outpatient.
- Females of child-bearing potential must use appropriate contraception.
- Diagnosis of seasonal allergic rhinitis to mountain cedar.
- Adequate exposure to allergen.
- Able to comply with study procedures.
- Literate.
- Exclusion criteria:
- Significant concomitant medical condition.
- Use of corticosteroids, allergy medications, or other medication that affect allergic rhinitis
- Positive pregnancy test.
- Allergy to any component of the investigational product.
- Tobacco use
- Contact lens use
- Has chickenpox or measles or recent exposure
- Other clinical trial drug exposure in last 30 days
- Affiliation with clinic site
Exclusion
Key Trial Info
Start Date :
December 20 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2007
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00435461
Start Date
December 20 2006
End Date
February 28 2007
Last Update
March 7 2018
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Austin, Texas, United States, 78731
2
GSK Investigational Site
Austin, Texas, United States, 78750
3
GSK Investigational Site
Kerrville, Texas, United States, 78028
4
GSK Investigational Site
New Braunfels, Texas, United States, 78130